Skip to main content
. 2021 Jun 25;11:683318. doi: 10.3389/fonc.2021.683318

Table 2.

Response to chemotherapy in SCLC patients.

Number ORR PFS (months)
First-line 99 74.7% (87 cases can be evaluated) 9.83
Second-line 36 11.1% 2.6
Third-line 11 0 2.4